Jason Hoitt, Chief Commercial Officer at Dova Pharmaceuticals Inc. (DOVA), sold 2,387 shares at $8.77 ($21K) on 2019-04-08, disclosed to the SEC on 2019-04-10.
Scheduled sale ($21k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PRVB | BUY | 2020-03-20 | $24K | — | Filing → |
| DOVA | SELL | 2019-10-02 | $67K | — | Filing → |
| DOVA | SELL | 2019-07-16 | $116K | — | Filing → |